|
Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study |
|
|
|
Titel: |
Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study |
Auteur: |
Callejo, Almudena Faouzi, Sara Bouché, Olivier Bertucci, François Chevalier, Thomas Isambert, Nicolas Duffaud, Florence Collard, Olivier Penel, Nicolas Terrier, Philippe Mir, Olivier Blay, Jean Yves Le Cesne, Axel |
Verschenen in: |
Targeted oncology |
Paginering: |
Jaargang 16 () nr. 4 pagina's 485-492 |
Jaar: |
2021-06-05 |
Inhoud: |
|
Uitgever: |
Springer International Publishing, Cham |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|